Preferences of Patients With HR+ & HER2- Breast Cancer Regarding Hormonal and Targeted Therapies in the First Line of Their Metastatic Stage: A Discrete Choice Experiment
Publication date: September 2021Source: Value in Health Regional Issues, Volume 25Author(s): Amir Nazari, Beatriz G. Lopez-Valcarcel, Safa Najafi
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hormones | International Medicine & Public Health